Data / Form D filings / NuvOx Therapeutics, Inc.
NuvOx Therapeutics, Inc.: Form D filings
NuvOx Therapeutics, Inc., a pharmaceuticals company in Tucson, AZ, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on November 22, 2024, reports $235,000 sold of a $7 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1635 E. 18TH STREET, Tucson, AZ, 85719
- Phone
- (520) 624-6688
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966126
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | New notice | $7,000,000 | $235,000 | $6,765,000 | 4 | Sep 10, 2024 | sec.gov |
| Feb 15, 2023 | New notice | $5,000,000 | $1,050,000 | $3,950,000 | 2 | Jan 31, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marvin J. Slepian | Director | |
| Richard T. Carmona | Director | |
| Jonathan T. Schilling | Director | |
| Jon Saxe | Director | |
| Rong Wang | Executive Officer | |
| Evan Unger | Executive Officer, Director | |
| Jennifer Johnson | Executive Officer |
Every Form D from the week of Nov 18, 2024 · All recent filings in Arizona · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NuvOx Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.